Literature DB >> 17061380

The moral difference between intragenic and transgenic modification of plants.

Bjorn K Myskja1.   

Abstract

Public policy on the development and use of genetically modified organisms (GMOs) has mainly been concerned with defining proper strategies of risk management. However, surveys and focus group interviews show that although lay people are concerned with risks, they also emphasize that genetic modification is ethically questionable in itself. Many people feel that this technology "tampers with nature" in an unacceptable manner. This is often identified as an objection to the crossing of species borders in producing transgenic organisms. Most scientists reject these opinions as based on insufficient knowledge about biotechnology, the concept of species, and nature in general. Some recent projects of genetic modification aim to accommodate the above mentioned concerns by altering the expression of endogenous genes rather than introducing genes from other species. There can be good scientific reasons for this approach, in addition to strategic reasons related to greater public acceptability. But are there also moral reasons for choosing intragenic rather than transgenic modification? I suggest three interrelated moral reasons for giving priority to intragenic modification. First, we should respect the opinions of lay people even when their view is contrary to scientific consensus; they express an alternative world-view, not scientific ignorance. Second, staying within species borders by strengthening endogenous traits reduces the risks and scientific uncertainty. Third, we should show respect for nature as a complex system of laws and interconnections that we cannot fully control. The main moral reason for intragenic modification, in our view, is the need to respect the "otherness" of nature.

Entities:  

Keywords:  Biomedical and Behavioral Research; Genetics and Reproduction

Mesh:

Year:  2006        PMID: 17061380     DOI: 10.1007/s10806-005-6164-0

Source DB:  PubMed          Journal:  J Agric Environ Ethics        ISSN: 1187-7863            Impact factor:   1.727


  6 in total

1.  Ethical Discourse about the Modification of Food for Therapeutic Purposes: How Patients with Gastrointestinal Diseases View the Good, the Bad, and the Healthy.

Authors:  Krista L Harrison; Gail Geller; Patricia Marshall; Jon Tilburt; Marybeth Mercer; Margaret A Brinich; Janelle Highland; Ruth M Farrell; Richard R Sharp
Journal:  AJOB Prim Res       Date:  2012-06-19

2.  Cytokinin vectors mediate marker-free and backbone-free plant transformation.

Authors:  Craig M Richael; Marina Kalyaeva; Robert C Chretien; Hua Yan; Sathya Adimulam; Artesia Stivison; J Troy Weeks; Caius M Rommens
Journal:  Transgenic Res       Date:  2008-03-05       Impact factor: 2.788

3.  Revisiting GMOs: Are There Differences in European Consumers' Acceptance and Valuation for Cisgenically vs Transgenically Bred Rice?

Authors:  Anne-Cécile Delwaide; Lawton L Nalley; Bruce L Dixon; Diana M Danforth; Rodolfo M Nayga; Ellen J Van Loo; Wim Verbeke
Journal:  PLoS One       Date:  2015-05-14       Impact factor: 3.240

4.  Somatic cell selection for chlorsulfuron-resistant mutants in potato: identification of point mutations in the acetohydroxyacid synthase gene.

Authors:  Philippa J Barrell; Julie M Latimer; Samantha J Baldwin; Michelle L Thompson; Jeanne M E Jacobs; Anthony J Conner
Journal:  BMC Biotechnol       Date:  2017-06-06       Impact factor: 2.563

5.  The three main monotheistic religions and gm food technology: an overview of perspectives.

Authors:  Emmanuel B Omobowale; Peter A Singer; Abdallah S Daar
Journal:  BMC Int Health Hum Rights       Date:  2009-08-22

6.  Bioengineering microbial communities: Their potential to help, hinder and disgust.

Authors:  Diane Sivasubramaniam; Ashley E Franks
Journal:  Bioengineered       Date:  2016-04       Impact factor: 3.269

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.